Real-time enrollment status for this type 1 diabetes clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 12:06 PM UTC
| NCT Number | NCT06783309 |
| Recruiting Status | Recruiting |
| Condition | Type 1 Diabetes |
| Phase | Clinical Trial |
| Target Enrollment | 72 participants |
| Active Locations | 18 sites in the US |
| Sponsor | COUR Pharmaceutical Development Company, Inc. |
| Last Updated on CT.gov | February 4, 2026 (3 weeks ago) |
As of March 2, 2026: Clinical trial NCT06783309 is currently recruiting participants. This clinical trial study for type 1 diabetes is actively seeking new participants at 18 locations across the United States. The study is sponsored by COUR Pharmaceutical Development Company, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06783309 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06783309 was last updated 3 weeks ago (February 4, 2026). HelloStudys verifies this status automatically.